Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug ...

Almost 40,000 years ago, a juvenile woolly mammoth died in modern-day Siberia. Today, its long-frozen remains have yielded ...

A research team has unveiled a small molecule that hunts down a cancer-enabling RNA and quietly erases it. Researchers have designed a groundbreaking drug molecule capable of precisely eliminating ...

The discovery of a juvenile woolly mammoth named Yuka, found in Siberian permafrost with its skin and muscles intact, has ...

In both humans and bacteria, viral infections lead to the activation of enzymes that generate cyclic nucleotides as messengers to start the immune response. However, how bacteria sense viral invasion ...

Scientists have managed to rescue the molecule, against all odds, from a calf that died after being attacked by cave lions ...

Scientists examine the mummified remains of a 39,000-year-old mammoth nicknamed Yuka, whose tissue yielded ancient RNA in a ...

Small, biologically inert molecules can be converted into bioactive degraders that selectively downregulate disease-causing RNAs. By attaching an RNA molecular recognition element to a second compound ...

A gene called MYC is implicated in the majority of cancers, but unfortunately it’s often considered “undruggable.” In a new study scientists have developed a molecule that chops up the RNA of this ...

Scientists have recently successfully isolated and sequenced the oldest-known RNA from a juvenile male woolly mammoth – ...

This report describes and explains the RNA targeting small molecules therapeutics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report ...